These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22481387)

  • 41. The Food and Drug Administration's Drug Safety Oversight Board: an evolving paradigm for clinical input on drug safety topics.
    Grandinetti CA; Osborne SF
    Clin Pharmacol Ther; 2010 Aug; 88(2):269-74. PubMed ID: 20531466
    [No Abstract]   [Full Text] [Related]  

  • 42. The FDA's new oncology office.
    Pazdur R
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):612-3. PubMed ID: 16167044
    [No Abstract]   [Full Text] [Related]  

  • 43. Reporting to the FDA.
    Dippel JV
    RN; 1993 Dec; 56(12):61-2. PubMed ID: 8265993
    [No Abstract]   [Full Text] [Related]  

  • 44. FDA guidance document on monitoring delayed adverse events a good first start.
    Williams DA
    Mol Ther; 2005 Dec; 12(6):991-2. PubMed ID: 16271514
    [No Abstract]   [Full Text] [Related]  

  • 45. MedWatch: the new medical products reporting program.
    Couig MP
    Crit Care Nurse; 1993 Aug; 13(4):13-7. PubMed ID: 8375176
    [No Abstract]   [Full Text] [Related]  

  • 46. Functionality test for drug safety alerting in computerized physician order entry systems.
    van der Sijs H; Bouamar R; van Gelder T; Aarts J; Berg M; Vulto A
    Int J Med Inform; 2010 Apr; 79(4):243-51. PubMed ID: 20149722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [FDA's new drug approval system].
    Ishii A
    Gan To Kagaku Ryoho; 1995 Aug; 22(9):1146-51. PubMed ID: 7661565
    [No Abstract]   [Full Text] [Related]  

  • 48. FDA announces MedWatch: a new reporting program for health professionals.
    Hopkinson SE
    AANA J; 1993 Aug; 61(4):373-8. PubMed ID: 8379285
    [No Abstract]   [Full Text] [Related]  

  • 49. Expedited safety reporting requirements for human drug and biological products; correction--FDA. Final rule; correction.
    Fed Regist; 1998 Mar; 63(58):14611-2. PubMed ID: 10177754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety alert for fentanyl buccal tablets.
    U.S. Food and Drug Administration
    J Pain Palliat Care Pharmacother; 2008; 22(1):47. PubMed ID: 19062355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase 0, Phase I in clinical research and the registering of publications.
    Caramori CA
    Rev Bras Cir Cardiovasc; 2013; 28(3):414-7. PubMed ID: 24498658
    [No Abstract]   [Full Text] [Related]  

  • 52. US Food and Drug Administration: adverse event reporting.
    Graham AA
    CRNA; 1998 Nov; 9(4):135-8. PubMed ID: 9866488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. US panel rules that warnings on two birth control pills be strengthened.
    Lenzer J
    BMJ; 2011 Dec; 343():d8104. PubMed ID: 22167795
    [No Abstract]   [Full Text] [Related]  

  • 54. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The FDA drug safety surveillance program: adverse event reporting trends.
    Weiss-Smith S; Deshpande G; Chung S; Gogolak V
    Arch Intern Med; 2011 Mar; 171(6):591-3. PubMed ID: 21444854
    [No Abstract]   [Full Text] [Related]  

  • 56. Bill Inman: drug safety physician and pharmacoepidemiologist.
    Shakir SA
    Drug Saf; 2006; 29(3):187-8. PubMed ID: 16524318
    [No Abstract]   [Full Text] [Related]  

  • 57. Worldwide reporting of fatal outcomes after ticagrelor to the US Food and Drug Administration.
    Serebruany VL; Kim MH; Marciniak TA
    Eur Heart J Cardiovasc Pharmacother; 2018 Jan; 4(1):6-9. PubMed ID: 29240872
    [No Abstract]   [Full Text] [Related]  

  • 58. WHO's international drug monitoring--the formative years, 1968-1975: preparatory, pilot and early operational phases.
    Venulet J; Helling-Borda M
    Drug Saf; 2010 Jul; 33(7):e1-e23. PubMed ID: 20553053
    [No Abstract]   [Full Text] [Related]  

  • 59. Standard 3: data monitoring committees.
    Ellenberg S; Fernandes RM; Saloojee H; Bassler D; Askie L; Vandermeer B; Offringa M; Van der Tweel I; Altman DG; van der Lee JH;
    Pediatrics; 2012 Jun; 129 Suppl 3():S132-7. PubMed ID: 22661759
    [No Abstract]   [Full Text] [Related]  

  • 60. Intraspinal steroids: history, efficacy, accidentality, and controversy with review of United States Food and Drug Administration reports.
    Nelson DA; Landau WM
    J Neurol Neurosurg Psychiatry; 2001 Apr; 70(4):433-43. PubMed ID: 11254764
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.